¿Hay diferencia en las características de los individuos con EPOC que exacerban o no durante un programa de rehabilitación pulmonar?

Autores/as

DOI:

https://doi.org/10.33448/rsd-v11i12.34290

Palabras clave:

Enfermedade pulmonar obstructiva crónica; Ejercicio físico; Brote de los síntomas.

Resumen

Objetivos: Identificar caracteristicas de individuos con enfermedad pulmonar obstructiva crónica (EPOC) que se exacerban o no durante un programa de entrenamiento físico (EF), y verificar si alguno de estos grupos es menos susceptible a los beneficios de lo EF. Métodos: Individuos con EPOC fueron evaluados para función pulmonar, fuerza muscular respiratoria, composición corporal, prueba de caminata de 6 minutos (6MWT), fuerza muscular periférica, calidad de vida, estado funcional, sensación de disnea em la vida diaria (escala Medical Research Council [MRC]), ansiedad y depresión. Individuos realizaron un programa de EF de alta intensidad con ejercicios aeróbicos y de fuerza (tres veces/semana, 12 semanas). Para el análisis, los individuos foran separados en dos grupos (Grupo que Exacerbó [GE] y Grupo que no exacerbó [GNE] y comparados em cuanto a sus características. Resultados: 44 individuos completaron el ET (26 en el GNE [VEF1 46±16%predicho] y 18 en el GE [VEF1 42±18%predicho]). En el preentrenamiento, los sujetos del GE eran más jóvenes, más ansiosos y con peor capacidad vital forzada. Después del ET, solo el GE mostró una mejora significativa en la disnea pre vs post entrenamiento: MRC (4[3–4] vs 3[2–4]; P=0,03) y solo el GNE en el 6MWT (478[424-519] vs 516[467–558]; P<0,0001). Finalmente, considerando la comparación del cambio post-pre ET, el GNE tuvo mejoría más pronunciada que el GE em calidad de vida y 6MWT. Conclusión: Los sujetos que exacerban durante el ET son menos susceptibles a los beneficios de el ET y necesitan sus propias estrategias de entrenamiento.

Citas

Alahmari, A. D., Kowlessar, B. S., Patel, A. R., Mackay, A. J., Allinson, J. P., Wedzicha, J. A., & Donaldson, G. C. (2016). Physical activity and exercise capacity in patients with moderate COPD exacerbations. Eur Respir J, 48(2), 340–349. https://doi.org/10.1183/13993003.01105-2015

Bernard, S., LeBlanc, P., Whittom, F., Carrier, G., Jobin, J., Belleau, R., & Maltais, F. (1998). Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 158(2), 629–634.

Bohn Júnior, I., Costa, C., Souza, R. M., Santos, Á., & Teixeira, P. (2020). Influence of pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease exacerbator phenotype. J Bras Pneumol, 46(6), e20190309. https://doi.org/10.36416/1806-3756/e20190309

Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., Jr, & Pereira, W. A. (1995). Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saúde Publica, 29(5), 355–363. https://doi.org/10.1590/s0034-89101995000500004

Britto, R. R., Probst, V. S., de Andrade, A. F., Samora, G. A., Hernandes, N. A., Marinho, P. E., Karsten, M., Pitta, F., & Parreira, V. F. (2013). Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther, 17(6), 556–563. https://doi.org/10.1590/S1413-35552012005000122

Carpes, M. F., Mayer, A. F., Simon, K. M., Jardim, J. R. & Garrod, R. (2008). The Brazilian Portuguese version of the London Chest Activity of Daily Living scale for use in patients with chronic obstructive pulmonary disease. J Bras Pneumol, 34, 143-51. https://doi.org/10.1590/S1806-37132008000300004

Carr, S. J., Goldstein, R. S., & Brooks, D. (2007). Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest, 132(1), 127–134. https://doi.org/10.1378/chest.07-0269

Consenso Brasileiro sobre Doença Pulmonar Obstrutiva Crônica II – DPOC. (2004). J Bras. Pneumol, 30(Supl 5), S1-42.

Decramer, M., Lacquet, L. M., Fagard, R., & Rogiers, P. (1994). Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med, 150(1), 11–16. https://doi.org/10.1164/ajrccm.150.1.8025735

Donaldson, G. C., Wilkinson, T. M., Hurst, J. R., Perera, W. R., & Wedzicha, J. A. (2005). Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171(5), 446–452. https://doi.org/10.1164/rccm.200408-1054OC

Dourado, V. Z., Tanni, S. E., Vale, S. A., Faganello, M. M., Sanchez, F. F., & Godoy, I. (2006). Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol, 32(2), 161–171. https://doi.org/10.1590/s1806-37132006000200012

Garcha, D. S., Thurston, S. J., Patel, A. R., Mackay, A. J., Goldring, J. J., Donaldson, G. C., McHugh, T. D. & Wedzicha, J. A. (2012). Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax, 67, 1075-1080.

Garcia-Rio, F., Rojo, B., Casitas, R., Lores, V., Madero, R., Romero, D., Galera, R., & Villasante, C. (2012). Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest, 142(2), 338–346. https://doi.org/10.1378/chest.11-2014

Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2022). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.org/.

Halpin, D., Decramer, M., Celli, B. R., Mueller, A., Metzdorf, N., & Tashkin, D. P. (2017). Effect of a single exacerbation on decline in lung function in COPD. Respir Med, 128, 85–91. https://doi.org/10.1016/j.rmed.2017.04.013

Hernandes, N. A., Teixeira, D., Probst, V. S., Brunetto, A. F., Ramos, E. M., & Pitta, F. (2009). Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol, 35(10), 949–956. https://doi.org/10.1590/s1806-37132009001000002

Holland, A. E., Spruit, M. A., Troosters, T., Puhan, M. A., Pepin, V., Saey, D., McCormack, M. C., Carlin, B. W., Sciurba, F. C., Pitta, F., Wanger, J., MacIntyre, N., Kaminsky, D. A., Culver, B. H., Revill, S. M., Hernandes, N. A., Andrianopoulos, V., Camillo, C. A., Mitchell, K. E., Lee, A. L., Hill, C. J., & Singh, S. J. (2014). An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J, 44(6), 1428–1446. https://doi.org/10.1183/09031936.00150314

Hopkinson, N. S., Tennant, R. C., Dayer, M. J., Swallow, E. B., Hansel, T. T., Moxham, J., & Polkey, M. I. (2007). A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. RespirRes, 8(1), 25. https://doi.org/10.1186/1465-9921-8-25

Jones, S. E., Barker, R. E., Nolan, C. M., Patel, S., Maddocks, M., & Man, W. (2018). Pulmonary rehabilitation in patients with an acute exacerbation of chronic obstructive pulmonary disease. J Thor Dis, 10(Suppl 12), S1390–S1399. https://doi.org/10.21037/jtd.2018.03.18

Kessler, R., Faller, M., Fourgaut, G., Mennecier, B., & Weitzenblum, E. (1999). Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 159(1), 158–164. https://doi.org/10.1164/ajrccm.159.1.9803117

Kovelis, D., Segretti, N. O., Probst, V. S., Lareau, S. C., Brunetto, A. F., & Pitta, F. (2008). Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol, 34(12), 1008–1018. https://doi.org/10.1590/s1806-37132008001200005

Kyle, U. G., Pichard, C., Rochat, T., Slosman, D. O., Fitting, J. W., & Thiebaud, D. (1998). New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J, 12(4), 960–966. https://doi.org/10.1183/09031936.98.12040960

Li, J., Sun, S., Tang, R., Qiu, H., Huang, Q., Mason, T. G., & Tian, L. (2016). Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Intern J COPD, 11, 3079–3091. https://doi.org/10.2147/COPD.S122282

Marino, D. M., Marrara, K. T., Arcuri, J. F., Candolo, C., Jamami, M., & Di Lorenzo, V. A. (2014). Determination of exacerbation predictors in patients with COPD in physical therapy - a longitudinal study. Braz J Phys Ther, 18(2), 127–136. https://doi.org/10.1590/s1413-35552012005000146

Mesquita, R., Donária, L., Genz, I. C., Pitta, F., & Probst, V. S. (2013). Respiratory muscle strength during and after hospitalization for COPD exacerbation. Respir care, 58(12), 2142–2149. https://doi.org/10.4187/respcare.02393

Miller, M. R., Crapo, R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., van der Grinten, C. P., Gustafsson, P., Jensen, R., Johnson, D. C., MacIntyre, N., McKay, R., Navajas, D., Pedersen, O. F., Pellegrino, R., Viegi, G., Wanger, J., & ATS/ERS Task Force (2005). General considerations for lung function testing. Eur Respir J, 26(1), 153–161. https://doi.org/10.1183/09031936.05.00034505

Moreira, G. L., Pitta, F., Ramos, D., Nascimento, C. S., Barzon, D., Kovelis, D., Colange, A. L., Brunetto, A. F., & Ramos, E. M. (2009). Portuguese-language version of the Chronic Respiratory Questionnaire: a validity and reproducibility study. J Bras Pneumol, 35(8), 737–744. https://doi.org/10.1590/s1806-37132009000800004

Neder, J. A., Andreoni, S., Lerario, M. C., & Nery, L. E. (1999). Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res, 32(6), 719–727. https://doi.org/10.1590/s0100-879x1999000600007

Pereira, C. A., Sato, T., & Rodrigues, S. C. (2007). New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol, 33(4), 397–406. https://doi.org/10.1590/s1806-37132007000400008

Pitta, F., Breyer, M. K., Hernandes, N. A., Teixeira, D., Sant'Anna, T. J., Fontana, A. D., Probst, V. S., Brunetto, A. F., Spruit, M. A., Wouters, E. F., Burghuber, O. C. & Hartl, S. (2009). Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med, 103, 421-6. https://doi.org/10.1016/j.rmed.2008.09.019

Pitta, F., Probst, V. S., Kovelis, D., Segretti, N. O., Mt Leoni, A., Garrod, R., & Brunetto, A. F. (2008). Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients. Rev Port Pneumol, 14(1), 27–47.

Pitta, F., Troosters, T., Probst, V. S., Langer, D., Decramer, M., & Gosselink, R. (2008). Are patients with COPD more active after pulmonary rehabilitation?. Chest, 134(2), 273–280. https://doi.org/10.1378/chest.07-2655

Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005). Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171(9), 972–977. https://doi.org/10.1164/rccm.200407-855OC

Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G., Message, S., Maccallum, P., Meade, T. W., Jeffries, D. J., Johnston, S. L., & Wedzicha, J. A. (2001). Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164(9), 1618–1623. https://doi.org/10.1164/ajrccm.164.9.2105011

Seemungal, T. A., Donaldson, G. C., Paul, E. A., Bestall, J. C., Jeffries, D. J., & Wedzicha, J. A. (1998). Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (5 Pt 1), 1418–1422. https://doi.org/10.1164/ajrccm.157.5.9709032

Soler-Cataluña, J. J., Martínez-García, M. A., Román Sánchez, P., Salcedo, E., Navarro, M., & Ochando, R. (2005). Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 60(11), 925–931. https://doi.org/10.1136/thx.2005.040527

Spitzer, K. A., Stefan, M. S., Priya, A., Pack, Q. R., Pekow, P. S., Lagu, T., Pinto-Plata, V. M., ZuWallack, R. L., & Lindenauer, P. K. (2019). Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries. Annals Am Thorac Soc, 16(1), 99–106. https://doi.org/10.1513/AnnalsATS.201805-332OC

Spruit, M. A., Gosselink, R., Troosters, T., De Paepe, K., & Decramer, M. (2002). Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J, 19(6), 1072–1078. https://doi.org/10.1183/09031936.02.00287102

Spruit, M. A., Gosselink, R., Troosters, T., Kasran, A., Gayan-Ramirez, G., Bogaerts, P., Bouillon, R., & Decramer, M. (2003). Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax, 58(9), 752–756. https://doi.org/10.1136/thorax.58.9.752

Spruit, M. A., Singh, S. J., Garvey, C., et al. (2013). An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 188(8), e13–e64. https://doi.org/10.1164/rccm.201309-1634ST

Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J., & Polkey, M. I. (2007). Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax, 62(2), 115–120. https://doi.org/10.1136/thx.2006.062026

Troosters, T., Demeyer, H., Hornikx, M., Camillo, C. A., & Janssens, W. (2014). Pulmonary rehabilitation. Clin Chest Med, 35(1), 241–249. https://doi.org/10.1016/j.ccm.2013.10.006

Williams, J. E., Singh, S. J., Sewell, L., Guyatt, G. H., & Morgan, M. D. (2001). Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax, 56(12), 954–959. https://doi.org/10.1136/thorax.56.12.954

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psych Scand, 67(6), 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Publicado

11/09/2022

Cómo citar

VICENTIN, M. R. .; BRITO, I. L.; HERNANDES, N. A.; PITTA, F. ¿Hay diferencia en las características de los individuos con EPOC que exacerban o no durante un programa de rehabilitación pulmonar?. Research, Society and Development, [S. l.], v. 11, n. 12, p. e188111234290, 2022. DOI: 10.33448/rsd-v11i12.34290. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/34290. Acesso em: 25 dic. 2024.

Número

Sección

Ciencias de la salud